by 
Enteral nutrition is the delivery of nutrients directly into the gastrointestinal tract, bypassing the organs of digestion. It is primarily used to provide nutrition to patients who cannot obtain nutrition through oral intake, including those with cognitive or swallowing issues and those with severe malnutrition requiring urgent replenishment of nutrients. Common enteral feeding tubes include nasogastric tubes, which are inserted through the nose into the stomach, and percutaneous endoscopic gastrostomy tubes, which are surgically placed directly into the stomach through the abdominal wall. The global enteral nutrition market is estimated to be valued at US$ 3.01 Bn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics: The enteral nutrition market is expected to be flourished by the rising prevalence of chronic diseases such as cancer, gastrointestinal diseases, and neurological disorders that often require feeding tube placement for nutrition delivery. According to the National Cancer Institute, in 2019, an estimated 1.8 million new cases of cancer were diagnosed in the United States. Similarly, as per the Centers for Disease Control and Prevention, over 60 million Americans suffer from gastrointestinal diseases. The growing incidence of such target diseases is driving the demand for enteral feeding tubes and formulas for nutrition support, thereby bolstering the market growth over the forecast period. Furthermore, the increasing cases of preterm births resulting in underdeveloped feeding in infants are also propelling the need for enteral nutrition products to prevent mortality and ensure proper growth and development in newborns.
Segment Analysis
The enteral nutrition market is segmented by protein composition into standardized and disease-specific formulations. Standardized formulations dominate the market and account for over 60% share owing to their easy availability and mass usage in general nutrition requirements. The disease specific formulations segment is growing at a faster pace due to increasing prevalence of chronic diseases and condition-specific formulas better addressing the nutritional needs.
PEST Analysis
Political: Regulations around nutritional formulations are getting stronger to ensure quality, safety, and efficacy. This imposes some compliance burden but overall supports market growth.
Economic: Rising income levels and improving healthcare accessibility is increasing demand for specialized nutrition therapy in developing nations. Growing aging population drives volume consumption globally.
Social: Disease awareness campaigns help patients recognize the importance of medical nutrition therapy. This boosts adoption. Growing health consciousness also raises self-administration of supplements.
Technological: Advanced formulation techniques allow customizing nutrient profile for individual needs. This enhances compliance and clinical outcomes. Digital tools facilitate remote monitoring of supplementation.
Key Takeaways
The global enteral nutrition market is expected to witness high growth at a CAGR of 5.8% during the forecast period of 2023 to 2030 to reach a market size of US$ 4.34 Bn by 2030. The market is driven by increasing prevalence of chronic diseases, growing geriatric population.
Regional analysis indicates North America dominates currently due to front ranking medical technologies and higher affordability for sophisticated nutrition therapies. Europe follows due to a well-established healthcare system and focus on quality care. Asia Pacific is anticipated to be the fastest growing region supported by growing medical expenditures, expanding patient access to healthcare facilities and newer product launches to address local disease patterns.
Key players operating in the enteral nutrition market are Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., Curtis Health Caps SP. Abbott leads globally with wide portfolio of products available globally for adult and pediatric needs. Nestle, Danone and Fresenius are other big names in both standardized and disease specific formulations.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
